Overview
Hiroshi Ikeuchi practices practicing medicine in Tokyo, Japan.
His clinical expertise encompasses EGFR Positive Lung Cancer and Oligodendroglioma.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroshi Ikeuchi
Is Hiroshi Ikeuchi a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroshi Ikeuchi is classified as an Experienced expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroshi Ikeuchi participate in research or clinical trials?
Yes. Hiroshi Ikeuchi has published 9 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Hiroshi Ikeuchi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMr. Ikeuchi isExperienced. Learn about EGFR Positive Lung Cancer.
- OligodendrogliomaMr. Ikeuchi isExperienced. Learn about Oligodendroglioma.